Cellular Adoptive Immunotherapy in Treating Patients With Stage III or Stage IV Ovarian Cancer or Primary Peritoneal Cancer
PHASE1CompletedINTERVENTIONAL
Enrollment
18
Participants
Timeline
Start Date
October 31, 2004
Study Completion Date
March 31, 2010
Conditions
Ovarian CancerPeritoneal Cavity Cancer
Interventions
BIOLOGICAL
therapeutic autologous lymphocytes
Trial Locations (1)
98109-1024
Fred Hutchinson Cancer Research Center, Seattle
All Listed Sponsors
lead
Fred Hutchinson Cancer Center
OTHER
NCT00101257 - Cellular Adoptive Immunotherapy in Treating Patients With Stage III or Stage IV Ovarian Cancer or Primary Peritoneal Cancer | Biotech Hunter | Biotech Hunter